UBS Group
CTEV

UBS Group’s Claritev Corp CTEV Stock Holding History

UBS Group’s Portfolio CTEV Stock Details CTEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-383
Closed -$157K – 8848
2020
Q3 		$157K Buy
+383
New +$168K ﹤0.01% 4931

Other funds holding CTEV

HFCIV
H&F Corporate Investors VIII San Francisco, California $63.5M AUM 20.79% 1-Year Est. Return
AM
Ares Management Los Angeles, California $1.52B AUM 12.97% 1-Year Est. Return
ACM
Arini Captial Management London, United Kingdom $634M AUM
PIF
Public Investment Fund Al Aqiq District, Riyadh, Saudi Arabia $12B AUM 0.61% 1-Year Est. Return
BPCM
Beach Point Capital Management Santa Monica, California $254M AUM 16.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CP
CPV Partners Stamford, Connecticut $224M AUM 77.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Caspian Capital New York $103M AUM
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

UBS Group's CTEV Position: Q1 2026 in Review

UBS Group increased its Claritev Corp (CTEV) stake by 58% in Q1 2026, buying an estimated $237K and bringing the position to 28,772 shares worth $470K. The position accounts for ﹤0.01% of the portfolio, ranked #6126.

UBS Group first reported a position in CTEV in Q3 2020 and has held it in 22 quarters since. The position peaked at $2.96M in Q3 2025. 94 funds tracked by Wall St. Rank hold CTEV as of Q1 2026.

  • UBS Group held 28,772 shares of Claritev Corp worth $470K as of Q1 2026.
  • UBS Group bought 10,579 Claritev Corp shares in Q1 2026, an estimated $237K.
  • Claritev Corp made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #6126 holding.
  • UBS Group first reported a position in Claritev Corp in Q3 2020 and has held it in 22 quarters since.
  • UBS Group's Claritev Corp position peaked at $2.96M in Q3 2025.
  • 94 funds tracked by Wall St. Rank held Claritev Corp as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.